Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: INmune Bio Inc., 3 years.
INmune Bio Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
INmune Bio Inc. June 16, 202683.8%
-
INmune Bio Inc. June 10, 202595.0%
-
INmune Bio Inc. July 19, 202495.1%
-
INmune Bio Inc. June 1, 202391.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | INmune Bio Inc. | Option exercise | +14,801 | $1.40 | $20,721 |
| Jun 25, 2024 | INmune Bio Inc. | Open-market purchase | +5,000 | $7.27 | $36,350 |
| Apr 19, 2024 | INmune Bio Inc. | Grant or award | +29,603 | $8.32 | $246,297 |
| Nov 10, 2023 | INmune Bio Inc. | Open-market purchase | +7,000 | $6.95 | $48,650 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.